Can we estimate the 'social' value of a QALY? Four core issues to resolve.
暂无分享,去创建一个
[1] Richard M. Smith,et al. Citizen, consumer or both? Reconceptualising demand in health care , 2017 .
[2] Richard D. Smith. Construction of the contingent valuation market in health care: a critical assessment. , 2003, Health economics.
[3] N. Devlin,et al. Cost-effectiveness Thresholds: Economic and Ethical Issues , 2002 .
[4] James K. Hammitt,et al. QALYs Versus WTP , 2002 .
[5] P. Dolan,et al. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? , 2002, Journal of health economics.
[6] R. Smith. The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation. , 2001, Health economics.
[7] Michael E. Chernew,et al. Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] S. Cunningham,et al. Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment. , 2000, Community dental health.
[9] J. Quiggin,et al. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? , 1999, Journal of health economics.
[10] E. Nord. Cost-Value Analysis in Health Care: Making Sense out of QALYS , 1999 .
[11] T Klose,et al. The contingent valuation method in health care. , 1999, Health policy.
[12] B. O'brien,et al. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. , 1998, Journal of clinical epidemiology.
[13] A Gafni,et al. Health care contingent valuation studies: a review and classification of the literature. , 1998, Health economics.
[14] M. Johannesson,et al. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[15] A. Garber,et al. Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.
[16] M. Johannesson. The relationship between cost-effectiveness analysis and cost-benefit analysis. , 1995, Social science & medicine.
[17] C E Phelps,et al. On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses , 1991, International Journal of Technology Assessment in Health Care.
[18] A. Culyer. THE NORMATIVE ECONOMICS OF HEALTH CARE FINANCE AND PROVISION , 1989 .
[19] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[20] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[21] John D. Arras,et al. Ethical Issues in Modern Medicine , 1977 .
[22] J. D. Graaff,et al. Theoretical welfare economics , 1957 .
[23] I. Little. A critique of welfare economics , 1951 .
[24] Nick Hanley,et al. Estimating the monetary value of health care: lessons from environmental economics. , 2003, Health economics.
[25] Graham Loomes,et al. Valuing Life Years and QALYs: Transferability and Convertability of Values Across the UK Public Sector , 2002 .
[26] Alan D. Lopez,et al. Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications , 2002 .
[27] I. Bateman. Economic valuation with stated preference techniques : a manual : department for transport , 2002 .
[28] J. Olsen,et al. Theory versus practice: a review of 'willingness-to-pay' in health and health care. , 2001, Health economics.
[29] A. Mcguire,et al. Providing health care : the economics of alternative systems of finance and delivery , 1991 .